Kunhwa Kim
Kunhwa Kim publishes mostly in Hematology, Oncology and Genetics, on topics such as Acute Myeloid Leukemia Research, Myeloproliferative Neoplasms: Diagnosis and Treatment and CAR-T cell therapy research.
- World rank
- #1,540,704 of 7,710,434 ranked researchers
- Rank in United States
- #481,473 of 1,627,098
- Works
- 64
- Citations
- 733
- Citations per work
- 11.5
What does Kunhwa Kim research?
Kunhwa Kim's work is mostly in Medicine (51%), Biochemistry, Genetics and Molecular Biology (14%), Immunology and Microbiology (6%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences3351.2%
- Medicine3351.2%
- Everything else1828.0%
- Life Sciences1320.8%
- 1Hematology25% of their works
- 2Oncology16% of their works
- 3Genetics10% of their works
- 4Molecular Biology9% of their works
- 5Immunology6% of their works
- 6Cancer Research5% of their works
Research topics
- Acute Myeloid Leukemia Research
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- CAR-T cell therapy research
- Multiple Myeloma Research and Treatments
- Cancer Genomics and Diagnostics
- Pneumocystis jirovecii pneumonia detection and treatment
- Histone Deacetylase Inhibitors Research
- Immunotherapy and Immune Responses
Which keywords describe Kunhwa Kim's research?
The keywords of their largest research topics: Acute Myeloid Leukemia, AML, Cancer Immunotherapy, CAR T Cells, Chimeric Antigen Receptor, JAK2 Mutation, Myelofibrosis and Diagnosis Criteria.
- Histone Deacetylases
- Dendritic Cells
- Pneumocystis
- Cancer Genomics
- Diagnosis Criteria
- JAK2 Mutation
- CAR T Cells
- Acute Myeloid Leukemia
- AML
- Cancer Immunotherapy
- Chimeric Antigen Receptor
- Myelofibrosis
- International Myeloma Working Group
- Mutational Signatures
- Pneumonia
- HDAC Inhibitors
- Immunity
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.
All 17 words, with their numbers
- AML271 topic
- Acute Myeloid Leukemia271 topic
- Cancer Immunotherapy152 topics
- CAR T Cells101 topic
- Chimeric Antigen Receptor101 topic
- JAK2 Mutation101 topic
- Myelofibrosis101 topic
- Diagnosis Criteria81 topic
- International Myeloma Working Group81 topic
- Cancer Genomics71 topic
- Mutational Signatures71 topic
- Pneumocystis61 topic
- Pneumonia61 topic
- Dendritic Cells51 topic
- HDAC Inhibitors51 topic
- Histone Deacetylases51 topic
- Immunity51 topic
Where does Kunhwa Kim work?
Kunhwa Kim's main affiliation in the publication record is The University of Texas MD Anderson Cancer Center, United States.
How many publications and citations does Kunhwa Kim have?
OpenAlex counts 64 works and 733 citations for Kunhwa Kim, an h-index of 12, ranking #1,540,704 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Kunhwa Kim. Posts are plain text and can be reported.